“Efficacy and safety of eltrombopag as thromboyetic agent in the treatment of immune thrombocytopenic purpura in patients that started treatment at Complejo Asistencial Universitario de León during the period 2012-2015

  • Pedro Gómez
    Universidad de Salamanca
  • María Asunción González
  • Aníbal Martín
  • Juan José Ortiz De Urbina
    Complejo Asistencial Universitario de León. jortiz[at]saludcastillayleon.es

Abstract

Immune thrombocytopenic purpura (ITP) is an autoinmune chronic disease that can lead to platelet count under 100.000/?L. Patients may develop purpuric lesions with possible hemorrhagic events. The diagnosis is made by exclusion and the treatment target is to obtain a platelet count superior to 100.000/?L.                                                                                                                                       Eltrombopag is an oral thrombopoietin receptor agonist, indicated for the second-line pharmacological treatment in splenectomized patients with chronic ITP and refractoriness to other treatments.                                                                                   The objetive of this study is to determine the efficacy and safety of the treatment. For this purpose, the dispensation registry and clinical histories of the treated patients during the period of 2012-2015 from Complejo Asistencial Universitario de León were revised.                                                                             Once the data was compiled and meticulously analysed, it can be concluded that: Most of the studied patients were able to reach the therapeutic target even though the platelet evolution didn't follow a linear progression, and the principal cause of suspension of the treatment was due to weak side effects
  • Referencias
  • Cómo citar
  • Del mismo autor
  • Métricas

“Efficacy and safety of eltrombopag as thromboyetic agent in the treatment of immune thrombocytopenic purpura in patients that started treatment at Complejo Asistencial Universitario de León during the period 2012-2015. (2017). FarmaJournal, 2(2), 59-67. https://revistas.usal.es/cinco/index.php/2445-1355/article/view/16013

Similar Articles

You may also start an advanced similarity search for this article.

Author Biography

Juan José Ortiz De Urbina

Complejo Asistencial Universitario de León.
Complejo Asistencial Universitario de León. Farmacia Hospitalaria. Altos de Nava s/n  24071, León · tfno: 987 23 74 00 (ext 43355)
+ −